![Agile research to complement agile development: a proposal for an mHealth research lifecycle | npj Digital Medicine Agile research to complement agile development: a proposal for an mHealth research lifecycle | npj Digital Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41746-018-0053-1/MediaObjects/41746_2018_53_Fig1_HTML.png)
Agile research to complement agile development: a proposal for an mHealth research lifecycle | npj Digital Medicine
![Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases - Journal of Allergy and Clinical Immunology Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/74b6b515-2def-41cc-99eb-58a2b72fa5cc/gr1_lrg.jpg)
Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases - Journal of Allergy and Clinical Immunology
![Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals](https://www.concertpharma.com/wp-content/uploads/2019/09/9-3-19-Persepectives-blog-What-is-Phase-1-2-3-image-for-9-3-19-final-.jpg)
Understanding Clinical Trial Terminology: What's a Phase 1, 2 or 3 Clinical Trial? - Concert Pharmaceuticals
![P079 - VISIONARY-MS: A Phase 2 Clinical Trial Of Catalytic Gold Nanocrystals, CNM-Au8, For The Treatment Of Chronic Optic Neuropathy - ACTRIMS Forum 2020 P079 - VISIONARY-MS: A Phase 2 Clinical Trial Of Catalytic Gold Nanocrystals, CNM-Au8, For The Treatment Of Chronic Optic Neuropathy - ACTRIMS Forum 2020](https://s3.us-west-2.amazonaws.com/us-cslide-prod-presentations/actrims/25/jpg/a303_1/thumbnails/0.png)
P079 - VISIONARY-MS: A Phase 2 Clinical Trial Of Catalytic Gold Nanocrystals, CNM-Au8, For The Treatment Of Chronic Optic Neuropathy - ACTRIMS Forum 2020
![Representative diagram for the results of phase I and phase II clinical... | Download Scientific Diagram Representative diagram for the results of phase I and phase II clinical... | Download Scientific Diagram](https://www.researchgate.net/publication/347884803/figure/fig1/AS:983546692915201@1611507213736/Representative-diagram-for-the-results-of-phase-I-and-phase-II-clinical-trials-of-the.png)
Representative diagram for the results of phase I and phase II clinical... | Download Scientific Diagram
![Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome - European Journal of Cancer Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2040696105/2054382709/gr1.jpg)
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcome - European Journal of Cancer
![The Coronavirus Clinical Trials Landscape: Why Clinical Trials are Vital to Addressing COVID-19 & How IMPAQ is Helping Track Them | IMPAQ International The Coronavirus Clinical Trials Landscape: Why Clinical Trials are Vital to Addressing COVID-19 & How IMPAQ is Helping Track Them | IMPAQ International](https://impaqint.com/sites/default/files/images/Asset%202%402x.png)
The Coronavirus Clinical Trials Landscape: Why Clinical Trials are Vital to Addressing COVID-19 & How IMPAQ is Helping Track Them | IMPAQ International
![CVM: Multikine's Phase 2 Trial Design May Have Grossly Understated Its Efficacy (NYSE:CVM) | Seeking Alpha CVM: Multikine's Phase 2 Trial Design May Have Grossly Understated Its Efficacy (NYSE:CVM) | Seeking Alpha](https://static.seekingalpha.com/uploads/2019/10/1/48808400-15699114648883371_origin.png)